Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1995-5-25
pubmed:abstractText
Interleukin-12 (IL-12), a cytokine with in vitro and in vivo immunomodulatory effects, is produced by lymphocytes and stimulated monocytes. Little is known about the production and possible role of IL-12 in human lymphoproliferative disorders. We examined IL-12 expression by immunohistochemistry using antibodies recognizing the p40, p35 subunits, and the p70 heterodimeric IL-12 protein, and by Northern blot in lymph nodes from patients with Hodgkin's disease (HD), non-Hodgkin's lymphomas (NHL), and nonneoplastic lymphoid lesions. In the majority of the HD cases (28 of 34), IL-12 immunoreaction was found in small lymphoid cells cultured around Hodgkin and Reed-Sternberg (H&RS) cells. No IL-12 signal was seen in H&RS cells. Transcripts for IL-12 were found by Northern and dot blot analysis in 13 of 19 (IL-12 p40) and 11 of 19 (IL-12 p35) cases. The HD cases were further examined for the presence of Epstein-Barr virus (EBV) latent membrane protein (LMP-1). All cases with EBV-LMP-1 positivity (22 of 34 cases) also expressed IL-12. No IL-12 immunoreaction was found in neoplastic cells of 33 cases of various NHLs, which were all LMP-1 negative and showed no EBV-genome sequence, as assessed by polymerase chain reaction (PCR). In 24 nonneoplastic lymphoid lesions, few dispersed IL-12 positive cells were seen in the parafollicular area and in the sinus of the lymph node. The marked presence of IL-12 in the majority of HD cases indicates that IL-12 might play a role in the pathobiology of HD, suggesting that this cytokine is involved in EBV-positive HD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2182-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7718889-Biological Markers, pubmed-meshheading:7718889-Gene Expression Regulation, Neoplastic, pubmed-meshheading:7718889-Gene Expression Regulation, Viral, pubmed-meshheading:7718889-Herpesviridae Infections, pubmed-meshheading:7718889-Herpesvirus 4, Human, pubmed-meshheading:7718889-Hodgkin Disease, pubmed-meshheading:7718889-Humans, pubmed-meshheading:7718889-Hyperplasia, pubmed-meshheading:7718889-Interleukin-12, pubmed-meshheading:7718889-Lymph Nodes, pubmed-meshheading:7718889-Lymphadenitis, pubmed-meshheading:7718889-Lymphoma, pubmed-meshheading:7718889-Lymphoma, Non-Hodgkin, pubmed-meshheading:7718889-Neoplasm Proteins, pubmed-meshheading:7718889-RNA, Messenger, pubmed-meshheading:7718889-RNA, Neoplasm, pubmed-meshheading:7718889-Reed-Sternberg Cells, pubmed-meshheading:7718889-Tumor Virus Infections, pubmed-meshheading:7718889-Viral Matrix Proteins
pubmed:year
1995
pubmed:articleTitle
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.
pubmed:affiliation
Laboratory for Clinical and Experimental Research, Berne, Switzerland.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't